DCI OF MIDDLE TENNESSEE LLC
NPI 1386592228
Clinic/Center - End-Stage Renal Disease (ESRD) Treatment in Paris, TN

NPI Status: Active since March 17, 2026

Contact Information

1101 KELLEY DR
PARIS, TN
ZIP 38242
Phone: (731) 644-0763
Fax: (731) 664-0751

Get Directions Write a Review

  • Organization
  • Clinic/Center
  • End-Stage Renal Disease (ESRD) Treatment
  • CLIA Number: 44D0315320
  • CLIA Cert. Type: End Stage Renal Disease Dialysis Facility
  • CLIA Exp. Date: 08-31-2026

About DCI OF MIDDLE TENNESSEE LLC

This page provides the complete NPI Profile along with additional information for Dci Of Middle Tennessee Llc, a provider established in Paris, Tennessee operating as a Clinic/center, focusing in end-stage renal disease (esrd) treatment . The healthcare provider is registered in the NPI registry with number 1386592228 assigned on March 2026. The practitioner's primary taxonomy code is 261QE0700X. The provider is registered as an organization and their NPI record was last updated March 2026. The authorized official of this NPI record is Donovan Schultz (President)

NPI
1386592228
Provider Name
DCI OF MIDDLE TENNESSEE LLC
Entity Type
Organization
Location Address
1101 KELLEY DR PARIS, TN 38242
Location Phone
(731) 644-0763
Location Fax
(731) 664-0751
Mailing Address
1633 CHURCH ST STE 500 NASHVILLE, TN 37203
Mailing Phone
(615) 342-0498
Mailing Fax
(731) 664-0751
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
03-17-2026
Last Update Date
03-17-2026
Code Navigator

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinic/Center End-Stage Renal Disease (ESRD) Treatment

Taxonomy Code
261QE0700X
Type
Ambulatory Health Care Facilities

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

DONOVAN SCHULTZ

Authorized Official Title
PRESIDENT
Authorized Official Phone
(615) 327-3061

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
44D0315320
Facility Type
End Stage Renal Disease Dialysis Facility
Certificate Effective Date
September 01, 2024
Certificate Expiration Date
August 31, 2026
Laboratory Director
DR. VICTOR NWAZUE
Certificate Type
Certificate of Waiver
Certificate Type Description
This CLIA certificate is issued to Dci Of Middle Tennessee Llc to perform only waived tests. CLIA defines waived tests as simple tests with a low risk for an incorrect result. Waived tests include certain tests listed in CLIA regulations, tests cleared by the FDA for home use and tests approved by the FDA for waived status and that meet CLIA waiver criteria.

Reviews for DCI OF MIDDLE TENNESSEE LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1386592228, we treat the final digit (8) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 62. The final step is to find the difference between that total and the next multiple of ten (70 - 62 = 8).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
3
Unchanged
Pos 3
8
Doubled → 16 → 1 + 6
Pos 4
6
Unchanged
Pos 5
5
Doubled → 10 → 1 + 0
Pos 6
9
Unchanged
Pos 7
2
Doubled → 4
Pos 8
2
Unchanged
Pos 9
2
Doubled → 4
Check
8
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 8 → 16 → 7 5 → 10 → 1 2 → 4 2 → 4

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 3 + 1 + 6 + 6 + 1 + 0 + 9 + 4 + 2 + 4 + 24 = 62

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 62 is 70. The difference is the calculated check digit.

70 - 62 = 8
This NPI is valid
The calculated check digit is 8, which matches the last digit of 1386592228.

Other Providers at the Same Location


The following 1 provider is registered at the same or a nearby location.

Clinic/Center (End-Stage Renal Disease (ESRD) Treatment)
1101 KELLEY DR
PARIS, TN 38242

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1386592228, enumerated as an "organization" on March 17, 2026.

The provider is located at 1101 KELLEY DR PARIS, TN 38242 and the phone number is (731) 644-0763.

Clinic/Center with taxonomy code 261QE0700X and a focus in End-Stage Renal Disease (ESRD) Treatment.